Quarterly Earnings Releases, Strategic Partnerships, and Scheduled Financial Results - Research Reports on Banco Bradesco, Blackstone, Teva, Apache and Noble

NEW YORK, November 4, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Banco Bradesco S.A. (NYSE: BBD), The Blackstone Group L.P. (NYSE: BX), Teva Pharmaceutical Industries Limited (NYSE: TEVA), Apache Corp. (NYSE: APA) and Noble Corp. Plc (NYSE: NE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7667-100free.

--
Banco Bradesco S.A. Research Reports
On October 30, 2014, Banco Bradesco S.A. (Banco Bradesco) announced its Q3 2014 financial results. Adjusted net income stood at (Brazilian Real) R$11.2 billion as compared to R$9.0 billion in Q3 2013. Assets under management stood at R$1.385 trillion, up 10.3% YoY. Total net interest income for the quarter was reported at R$12.3 billion versus R$10.7 billion in Q3 2013. Fee and Commission Income came in at R$5.6 billion up 13.3% YoY. The full research reports on Banco Bradesco are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/BBD/report.pdf

--
The Blackstone Group L.P. Research Reports
On October 21, 2014, The Blackstone Group L.P. (Blackstone) announced a partnership with a highly experienced management team, led by Matthew Rosenblum, the Founder and CEO at Solops, LLC, to create Onyx Renewable Partners (Onyx). According to the Company, Onyx, which will be a new affiliate of Blackstone portfolio company - Fisterra Energy (Fisterra), will be owned by funds managed by Blackstone on behalf of its private equity investors. Blackstone stated that Onyx's primary focus will be to develop, finance, construct and operate utility scale wind and solar renewable power projects in North America. Sean Klimczak, a Senior Managing Director of Blackstone who oversees Blackstone's power investments, said, "We are very pleased to have this opportunity to partner with Matt and the entire Onyx management team to identify and to develop North American renewable power projects. Onyx will expand Blackstone's and Fisterra's existing global footprint, add new renewable generation to our nation's grid and create value for all stakeholders involved." The full research reports on Blackstone are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/BX/report.pdf

--
Teva Pharmaceutical Industries Limited Research Reports
On October 30, 2014, Teva Pharmaceutical Industries Limited (Teva) announced it Q3 2014 financial results. Revenues were flat at $5.1 billion. Net income was reported at $876 million or $1.02 per diluted share, compared to $711 million or $0.84 per diluted share in Q3 2013. Non-GAAP diluted EPS stood at $1.32 compared to $1.27 in Q3 2013. Erez Vigodman, President & CEO of Teva said, "The effort we have put forth thus far in 2014 towards solidifying our foundation to drive organic growth is reflected in our strong third quarter results. We delivered improvement in profitability in all businesses, particularly in global generics, which saw profitability increase by 40% year over year." Erez Vigodman added, "We are well positioned to achieve our goals for 2014. Additionally, our Board of Directors has approved to resume and increase our share repurchase program. Leveraging our strong cash flow, we will continue to focus on creating value through a balanced approach to capital allocation via dividend distribution and share repurchases while continuing to pursue strategic business development opportunities." For full-year 2014, the Company updated its non-GAAP diluted EPS expectations to $5.00- $5.10 from its prior guidance of $4.90-$5.10 as announced in July 2014. The full research reports on Teva are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/TEVA/report.pdf

--
Apache Corp. Research Reports
On October 23, 2014, Apache Corp. (Apache) announced that the Company will release its Q3 2014 results on Thursday, November 6, 2014, at 7:00 a.m. CT. According to the Company, the earnings release will be followed by a conference call to discuss the results on the same day at 1:00 p.m. CT. Apache added that the call along with the replay will be webcast through its website. The full research reports on Apache are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/APA/report.pdf

--
Noble Corp. Plc Research Reports
On October 29, 2014, Noble Corp. Plc (Noble) announced its Q3 2014 financial results with operating revenues at $828.8 million versus $640.5 million in Q3 2013. The Company's total contract backlog at September 30, 2014 was estimated to be $10.6 billion, compared to $11.1 billion at June 30, 2014. Net income from continuing operations was reported at $147 million, or $0.57 per diluted share, compared to $165 million, or $0.64 per diluted share, in Q3 2013. David W. Williams, Chairman, President and CEO of Noble noted, "During the third quarter, we commenced operations on two newbuild additions to the Noble fleet - the ultra-deepwater drillship Noble Sam Croft in the U.S. Gulf of Mexico and the high-specification jackup Noble Sam Turner in the North Sea. Combined, the two rigs added more than $50 million to quarterly revenues during the limited time they were working, contributing to the 4 percent growth in contract drilling services revenues when compared to the second quarter." The full research reports on Noble are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/NE/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review